The Scientific World Journal

The Scientific World Journal / 2003 / Article
Special Issue

Selected Papers on Disease and Disease Processes

View this Special Issue

Mini-Review Article | Open Access

Volume 3 |Article ID 586028 | https://doi.org/10.1100/tsw.2003.39

Rosa Rademakers, Marc Cruts, Christine Van Broeckhoven, "Genetics of Early-Onset Alzheimer Dementia", The Scientific World Journal, vol. 3, Article ID 586028, 23 pages, 2003. https://doi.org/10.1100/tsw.2003.39

Genetics of Early-Onset Alzheimer Dementia

Academic Editor: Rudy Tanzi

Abstract

Alzheimer�s dementia (AD) is the most common degenerative disorder of the central nervous system. Although the onset of dementia is above 65 years of age in the majority of the patients (late-onset AD, LOAD), a small subgroup of patients develops AD before 65 years of age (early-onset AD, EOAD). To date 3 genes responsible for EOAD have been identified: the amyloid precursor protein gene (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2). PSEN1 is the most frequently mutated EOAD gene with a mutation frequency of 18 to 50% in autosomal dominant EOAD. In addition, the e4 allele of the gene encoding apolipoprotein E (APOE) was identified as a risk factor for both LOAD and EOAD. Many studies reported other susceptibility genes, but the APOE?4 alelle has been the only risk factor that was consistently replicated in all AD populations. Extensive cell biology research in the past ten years led to the hypothesis that the 4 EOAD genes lead to AD through a common biological pathway resulting in abnormal APP processing by subtle different mechanisms. Now, transgenic mice are produced to study the influence of EOAD mutations in vivo, eventually leading to the development of novel therapeutic strategies.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views420
Downloads1803
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.